Call 1-888-805-4555
for 24/7 on-call assistance
Bristol Myers Squibb is committed to delivering optimal patient and customer experience with cellular therapies. This information will help prescribed patients get access to our CAR T cell therapies and help treatment centers navigate the reimbursement process.
Benefit verification, prior authorization, and/or single case agreement (if required).
Prior to apheresis scheduling.
Enrollment for financial, logistical, and/or coverage verification assistance (online or fax).
Patients can enroll at any point during the CAR T cell therapy treatment process; however, for optimal personalized assistance, it is recommended to enroll patients in support programs prior to apheresis scheduling.*
*Eligibility requirements may apply.
Product order placed for purchase via authorized distributor’s online portal.
In a timely manner after apheresis scheduling.
Information you may need to complete your claim.
After product administration.
Visit the Resource Library for informative downloadable tools.
This information is provided for educational purposes only. Bristol Myers Squibb cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care and may be subject to frequent change. It is the sole responsibility of the healthcare provider to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.
CAR=chimeric antigen receptor.
You are now entering the Cell Therapy 360® Scheduling and Apheresis Portal.
You are about to leave this Bristol-Myers Squibb Company site. You are being redirected to another Bristol-Myers Squibb Company site.
You are now leaving this Bristol Myers Squibb site.
This internet site may provide links or references to other sites. BMS has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this internet site.
Are you sure you want to leave the enrollment section?
Your work will not be saved until you fill out the Patient Authorization and Consent page and submit your part of the enrollment form.
It won’t take long!
You are about to leave this Bristol-Myers Squibb Company site. You are being redirected to another Bristol-Myers Squibb Company site.
Please confirm your patient’s diagnosis:
Please confirm that you are a:
You are about to leave this Bristol-Myers Squibb Company site. You are being redirected to another Bristol-Myers Squibb Company site.
Select a disease state:
R/R=relapsed/refractory.
You are about to leave this Bristol-Myers Squibb Company site. You are being redirected to another Bristol-Myers Squibb Company site.
Insurance coverage information is currently available for R/R large B-cell lymphoma only.
R/R=relapsed/refractory.
You are about to leave this Bristol-Myers Squibb Company site. You are being redirected to another Bristol-Myers Squibb Company site.
Please confirm your patient’s diagnosis:
R/R=relapsed/refractory.